Journal
Journal of Experimental Medicine
Publication Date
2011
Volume
208
Issue
10
First Page
1989
Last Page
2003
Document Type
Open Access Publication
DOI
10.1084/jem.20101158
Rights and Permissions
Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, Archambault JM, Lee H, Arthur CD, White JM, Kalinke U, Murphy KM, Schreiber RD. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med. 2011 Sep 26;208(10):1989-2003. doi: 10.1084/jem.20101158. Epub 2011 Sep 19. © 2011 Diamond et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
Recommended Citation
Diamond, Mark S.; Kinder, Michelle; Matsushita, Hirokazu; Mashayekhi, Mona; Dunn, Gavin P.; Archambault, Jessica M.; Lee, Hsiaoju; Arthur, Cora D.; White, J Michael; Kalinke, Ulrich; Murphy, Kenneth M.; and Schreiber, Robert D., "Type I interferon is selectively required by dendritic cells for immune rejection of tumors." Journal of Experimental Medicine. 208, 10. 1989 - 2003. (2011).
https://digitalcommons.wustl.edu/open_access_pubs/8548
